Where the actives come from
The two growth factors in OF·27 are made by molecular farming. Instead of steel bioreactors, the protein is grown in the seeds of Camelina sativa, an oilseed crop. The platform was built by Core Biogenesis, the French biotechnology company that develops and supplies the actives.
Growing a protein in a crop changes the economics and logistics of making it. For the formula, what matters is the carrier: growing the growth factor in the seed alongside the oleosome yields a protein that is already bound to its oil body and already stable, the fusion described in Note 05.
Our role is different from theirs. Core Biogenesis develops the actives and commissioned the independent study of the FGF·2 active. OF·27 formulates those actives into a documented protocol and cites that study. Note 08 covers how the study measured, Note 09 what it found.
What is Core Biogenesis?
A French biotechnology company founded in 2020 in Strasbourg that produces recombinant proteins by expressing them in Camelina sativa. It develops and supplies the actives used in OF·27 and commissioned the study OF·27 cites.
What is molecular farming?
The production of a recombinant protein inside a plant, here the seeds of an oilseed crop, in place of conventional bioreactor culture.
The notes, by email.
One note at a time, in reading order, and a message when a new one is published.
An independent hair-science program.
The protocol the notes describe: The OF·27 Protocol
OF·27 is marketed as a cosmetic and is not intended to diagnose, treat, cure or prevent any disease.